Zobrazeno 1 - 10
of 262
pro vyhledávání: '"I. Aronson"'
Autor:
Kerri I. Aronson, Mangala Rajan, Janani Varadarajan, Tessy K. Paul, Jeffrey J. Swigris, Jamuna K. Krishnan, Robert J. Kaner, Fernando J. Martinez, Monika M. Safford, Laura C. Pinheiro
Publikováno v:
ERJ Open Research, Vol 10, Iss 4 (2024)
Rationale and objective Disease-specific health-related quality of life (HRQOL) instruments enable us to capture domains that are most relevant to specific patient populations and are useful when a more individualised approach to patient assessment i
Externí odkaz:
https://doaj.org/article/569a28d2189c441da7a1ea7ece7d9b89
Autor:
Amy, I. Aronson-Friedman, author, Kaplan, Gregory B., author
Publikováno v:
Marginal Voices. 46:1-17
Publikováno v:
Respiratory Research, Vol 22, Iss 1, Pp 1-10 (2021)
Abstract Background Chronic hypersensitivity pneumonitis (CHP) is an interstitial lung disease (ILD) caused by long term exposure to an offending antigen. Antigen avoidance is associated with improved outcomes. We are unable to identify the antigen s
Externí odkaz:
https://doaj.org/article/1e55b7081360440589cee1b9d870b835
The conversos of late medieval and Golden Age Spain were Christians whose Jewish ancestors had been forced to change faiths within a society that developed a preoccupation with pure Christian lineage. The aims of this book is to shed new light on the
Autor:
Kerri I. Aronson, Maha Ali, Evgeniya Reshetynak, Robert J. Kaner, Fernando J. Martinez, Monika M. Safford, Laura C. Pinheiro
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-10 (2021)
Abstract Background Chronic Hypersensitivity Pneumonitis (CHP) is caused by an immune mediated response in the lung tissue after exposure to an inhaled environmental antigenic stimulant. We previously documented the ways in which CHP impacts patients
Externí odkaz:
https://doaj.org/article/4adca6eb91b6477681ea4d0256066cec
Autor:
Kerri I. Aronson, Atsushi Suzuki
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Health-Related Quality of Life (HRQOL) is increasingly viewed as an important patient-centered outcome by leading health organizations, clinicians, and patients alike. This is especially true in the interstitial lung disease community where patients
Externí odkaz:
https://doaj.org/article/0325636d425647a3a94e10ff6473a5c5
Autor:
Michaela R. Anderson, Kerri I. Aronson, Joshua M. Diamond, Jason D. Christie, Jonathan P. Singer
Publikováno v:
Annals of the American Thoracic Society.
Autor:
Jamuna K. Krishnan, Joseph K. Shin, Maha Ali, Meredith L. Turetz, Bradley J. Hayward, Lindsay Lief, Monika M. Safford, Kerri I. Aronson
Publikováno v:
ATS Scholar. 3:561-575
Publikováno v:
BMJ Open Respiratory Research, Vol 6, Iss 1 (2019)
Rationale Chronic hypersensitivity pneumonitis (CHP) is a distinct form of interstitial lung disease caused by an inhaled environmental antigen. Some patients with CHP develop progressive pulmonary fibrosis and varying degrees of symptom severity, wi
Externí odkaz:
https://doaj.org/article/555edf73b5a14bb88400cbfd2f520fef
Autor:
Irene Y. Chong, Christopher J. Lord, Wojciech Niedzwiedz, Syed Haider, Andres Cervantes, Johann de Bono, Stephen J. Pettitt, Jyoti Choudhary, Theodoros Roumeliotis, Ana Ferreira, Ruth Riisnaes, Bora Gurel, Frank T. Zenke, Astrid Zimmermann, Rachel Brough, Ronan Broderick, Malgorzata Dylewska, Feifei Song, John Alexander, Jadwiga Nieminuszczy, Dragomir B. Krastev, Lauren I. Aronson, Marta J. Llorca-Cardenosa
Supplementary Table from SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e7bde9d3ff1abb9ef60efb2134cb7ae
https://doi.org/10.1158/0008-5472.22433010
https://doi.org/10.1158/0008-5472.22433010